25504632Kendra KL, Plummer R, Salgia R, O'Brien ME, Paul EM, Suttle AB, Compton N, Xu CF, Ottesen LH, Villalona-Calero MAMolecular cancer therapeuticsAntineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Neoplasms; Paclitaxel; Pyrimidines; SulfonamidesAdult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Humans; Indazoles; Leukocyte Count; Male; Middle Aged; Neoplasm StagingA multicenter phase I study of pazopanib in combination with paclitaxel in first-line treatment of patients with advanced solid tumors. Mol Cancer Ther. 2015 Feb; 14(2):461-9.Mol Cancer Ther2014-12-10T00:00:002014A multicenter phase I study of pazopanib in combination with paclitaxel in first-line treatment of patients with advanced solid tumors.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000369Living Beings93664810.461294Aged, 80 and overD000368Living Beings1341183530.294764AgedD000328Living Beings1578255770.254432AdultD000970Chemicals & Drugs40723510.435461Antineoplastic AgentsD000971Procedures30624340.476235Antineoplastic Combined Chemotherapy ProtocolsD004305Concepts & Ideas52019580.724084Dose-Response Relationship, DrugD007191Chemicals & Drugs37680.957307IndazolesD008875Concepts & IdeasLiving Beings1473249570.258811Middle AgedD009367Concepts & IdeasProcedures34719320.670065Neoplasm StagingD005260Physiology1992444050.191167FemaleD006801Living Beings2262862810.130052HumansD007958Concepts & IdeasPhenomenaProcedures1052200.957291Leukocyte CountD008297Physiology1931408600.201617MaleD017239Chemicals & Drugs1164600.850613PaclitaxelD011743Chemicals & Drugs1373700.795259PyrimidinesD013449Chemicals & Drugs1502990.834179SulfonamidesD009369Disorders55628890.33847NeoplasmsMedicineUniversity of ChicagoRaviSalgiaRavi Salgia41.78927490000000-87.601250000000001937Salgia, RaviEmeritus/Emerita, Professortrue1Emeritus/Emerita, ProfessorEmeritus/Emerita, ProfessorAuthorship 7606730.1312350.1312351authors10.2517has subject area